Trends in FDA approval of novel therapies in women's cancer: A study of the last 25 years

Brittany File; Alex Francoeur; Nathan Tran; Michael Richardson; Daniel Kapp; Bradley Monk; Thomas Herzog; Robert Coleman; Krishnansu Tewari; John Chan

doi:10.1016/j.ygyno.2025.04.125

Back

Trends in FDA approval of novel therapies in women's cancer: A study of the last 25 years

Journal article

Peer reviewed

Trends in FDA approval of novel therapies in women's cancer: A study of the last 25 years

Brittany File, Alex Francoeur, Nathan Tran, Michael Richardson, Daniel Kapp, Bradley Monk, Thomas Herzog, Robert Coleman, Krishnansu Tewari and John Chan

Gynecologic oncology, Vol.200, pp.114-115

09/2025

DOI: https://doi.org/10.1016/j.ygyno.2025.04.125

Metrics

5 Record Views

Details

Title: Trends in FDA approval of novel therapies in women's cancer: A study of the last 25 years
Creators: Brittany File
Alex Francoeur
Nathan Tran
Michael Richardson
Daniel Kapp
Bradley Monk
Thomas Herzog
Robert Coleman
Krishnansu Tewari
John Chan
Publication Details: Gynecologic oncology, Vol.200, pp.114-115
Identifiers: 991006226263502656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article

Trends in FDA approval of novel therapies in women's cancer: A study of the last 25 years

Related links

Metrics

Details

Trends in FDA approval of novel therapies in women's cancer: A study of the last 25 years